Baraclude is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. It inhibits viral replication in liver cells, helping to reduce viral load and improve liver function. It is an important part of a treatment plan aimed at controlling the disease and limiting its complications, such as cirrhosis or the development of liver cancer. Baraclude must be used under a physician's supervision to ensure maximum therapeutic benefit and long-term liver protection.
This medication improves the results of laboratory tests related to liver function, reduces inflammation within liver cells, and enhances the body's ability to restore normal functions. Regular use of Baraclude according to the prescribed doses helps maintain continuous control of the virus, reduces the likelihood of relapses, and provides the patient with effective support in combating the disease, which improves their overall health and quality of life.